デフォルト表紙
市場調査レポート
商品コード
1433632

3D細胞培養の市場規模、シェア、動向分析レポート:技術別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年

3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 125 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
3D細胞培養の市場規模、シェア、動向分析レポート:技術別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年01月25日
発行: Grand View Research
ページ情報: 英文 125 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

3D細胞培養市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の3D細胞培養市場規模は2030年までに32億1,000万米ドルに達すると予測され、2024年から2030年にかけてCAGR 11.22%で拡大すると予測されています。

この市場を牽引しているのは、体外検査モデルの技術的進歩、個別化医療への注目の高まり、研究開発に対する政府の支援法です。さらに、慢性疾患の有病率の増加と、その治療における細胞治療の重要性の高まりが、業界拡大の勢いを生み出しています。

組織工学は、従来の2D細胞培養よりも生体内培養液をより正確に模倣した3D培養モデルの作成において著しい発展を遂げました。その結果、毒性試験、創薬、再生医療開発に3D細胞培養システムの利用が増加しました。また、業界各社による最近の製品発表も市場の成長を大きく後押ししています。例えば、2023年6月、Pixelgen Technologies社は、細胞表面に存在するタンパク質の3D空間研究のための初の分子ピクセル化キットを発売しました。

さらに、マイクロ流体工学、バイオプリンティング、ハイコンテントスクリーニングシステムなどの先端技術の開発が、これらのモデルの能力を活用しています。これらの技術により、培養条件、細胞組織、高効率スクリーニングの実施能力に対する優れた制御が可能になり、3D培養システムの活用に拍車がかかっています。さらに、培養モデルの開発にバイオプリンティング技術やマイクロ流体工学技術を活用するための市場関係者間の協力関係の強化が、市場の成長を後押ししています。例えば、AIM BiotechとMatTekは2023年6月に提携し、革新的なidenTXおよびorganiXマイクロ流体3D組織培養プラットフォームを、神経生物学、免疫腫瘍学、血管生物学の特定分野における完全な創薬研究サービスとともに提供しています。

3D培養は、臓器の典型的な微細構造や形態を忠実に再現することができるため、体組織や臓器に対する薬物の効果を分析するためにin vivoモデルを必要とする研究のために継続的に開発されています。この要因は、様々な体外応用のための足場の材料や構造の点でいくつかの選択肢が利用可能であることと相まって、足場の収益を押し上げると予想されます。最近の調査では、グラフェン足場、ナノファイバー、天然海洋コラーゲン、凍結鋳造など、幅広い足場の使用が検討されています。さらに、増殖、刺激、生存率、輸送、高含量スクリーニング、パッチクランピング、代謝活性など、いくつかの種類のアッセイにおけるラボオンチップなどの技術の新たな応用は、高度で効率的なソリューションに対する需要の増加につながると予想されます。

しかし、3D細胞モデル製品の一貫性の欠如は、市場の成長を妨げると予想される主要な欠点の一つです。さらに、細胞培養のばらつき、標準化の課題、スケールと製造の問題、品質管理の問題など、さまざまな要因が市場成長の妨げになる可能性があります。

3D細胞培養市場レポートハイライト

  • 2023年には、足場ベースの技術セグメントが48.94%の収益シェアで市場を独占しており、これは組織工学および再生医療用途における足場ベースの培養の応用が増加していることに起因しています。
  • 2023年には、幹細胞研究・組織工学が最大のシェアを占めました。一方、がん研究セグメントは、がんの有病率の上昇とがん研究において3D細胞培養が提供する利点により、最も速い成長が見込まれています。
  • 最終用途分野では、バイオテクノロジー企業・製薬企業が2023年の収益シェアで市場を独占しました。高い収益成長は、バイオ医薬品の継続的な成長と商業的成功、大手製薬会社のポートフォリオの拡大に起因します。
  • 北米地域は、2023年に38.97%の収益シェアで世界市場を独占しました。これは、高度なヘルスケアインフラの存在、新興経済諸国、主要プレイヤーの存在、それらによって実施された様々な戦略的イニシアチブによるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 技術のビジネス分析

  • 3D細胞培養市場:技術の変動分析
  • 足場ベース
  • 足場フリー
  • バイオリアクター
  • マイクロ流体力学
  • バイオプリンティング

第5章 用途のビジネス分析

  • 3D細胞培養市場:用途の変動分析
  • がん研究
  • 幹細胞研究・組織工学
  • 医薬品開発・毒性試験
  • その他

第6章 最終用途のビジネス分析

  • 3D細胞培養市場:最終用途の変動分析
  • バイオテクノロジー企業・製薬企業
  • 学術・研究機関
  • 病院
  • その他

第7章 地域のビジネス分析

  • 3D細胞培養のシェア:地域別、2023年および2030年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市況分析、2023年
  • 企業プロファイル/リスト
    • Thermo Fisher Scientific, Inc
    • Merck KGaA
    • PromoCell GmbH
    • Lonza
    • Corning Incorporated
    • Avantor, Inc.
    • Tecan Trading AG
    • REPROCELL Inc.
    • CN Bio Innovations Ltd.
    • Lena Biosciences
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global 3D cell culture market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 12 Canada 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Europe 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Europe 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 16 Europe 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 19 Germany 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 UK 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 22 UK 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 France 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 25 France 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Italy 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 28 Italy 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Spain 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 31 Spain 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Denmark 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 34 Denmark 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Sweden 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 37 Sweden 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Norway 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 40 Norway 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 China 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 47 China 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Japan 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 50 Japan 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 India 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 53 India 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 South Korea 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Korea 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Korea 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Australia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 59 Australia 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Thailand 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Thailand 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 62 Thailand 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 64 Latin America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 66 Latin America 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 69 Brazil 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Mexico 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 72 Mexico 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Argentina 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 75 Argentina 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 MEA 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 77 MEA 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 78 MEA 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 79 MEA 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 South Africa 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 82 South Africa 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 UAE 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 88 UAE 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 Kuwait 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 91 Kuwait 3D cell culture market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 3D cell culture market: market outlook
  • Fig. 9 Parent market outlook
  • Fig. 10 3D cell culture market driver impact
  • Fig. 11 3D cell culture market restraint impact
  • Fig. 12 3D cell culture market: technology outlook and key takeaways
  • Fig. 13 3D cell culture market: technology movement analysis
  • Fig. 14 Scaffold based market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Scaffold free market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Hanging drop microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Spheroid microplates with ULA coating market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Magnetic levitation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Bioreactors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 3D cell culture market: application outlook and key takeaways
  • Fig. 27 3D cell culture market: application movement analysis
  • Fig. 28 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug development & toxicity testing market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 3D cell culture market: end-use outlook and key takeaways
  • Fig. 33 3D cell culture market: end-use movement analysis
  • Fig. 34 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Hospitals market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 North America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Spain 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Norway 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 China 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Japan 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 India 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Australia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million) 
目次
Product Code: GVR-1-68038-091-0

3D Cell Culture Market Growth & Trends:

The global 3D cell culture market size is anticipated to reach USD 3.21 billion by 2030 and is anticipated to expand at a CAGR of 11.22% during 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in in-vitro testing models, a rising focus on personalized medicine, and supportive government legislation for R&D. Moreover, the increasing prevalence of chronic disorders, and the growing significance of cell therapies in their treatment have created momentum for industry expansion.

Tissue engineering has made significant developments in creating 3D culture models that mimic the in-vivo culture media more precisely than the conventional 2D cell cultures. This resulted in increased utilization of 3D cell culture systems for toxicity testing, drug discovery, and regenerative medicine development. Also, recent product launches from industry players have supported market growth to a significant extent. For instance, in June 2023, Pixelgen Technologies launched its first molecular pixelation kit for 3D spatial study of proteins present on cell surface.

In addition, the development of advanced technologies like microfluidics, bioprinting, and high-content screening systems, has leveraged the capabilities of these models. These technologies allow excellent control over culture conditions, cell organization, and the capability to perform high-efficiency screening, thereby fueling the utilization of 3D culture systems. Moreover, increased collaboration between market players to utilize bioprinting and microfluidics techniques in developing culture models has propelled market growth. For instance, in June 2023, AIM Biotech and MatTek partnered together to offer innovative idenTX and organiX microfluidic 3D tissue culture platforms along with complete drug discovery research services in specific areas of neurobiology, immune-oncology, and vascular biology.

3D cultures can closely replicate the typical microarchitecture and morphology of organs and hence are continuously developed for studies that require in vivo models to analyze the effect of a drug over body tissues and organs. This factor, coupled with the availability of several choices in terms of the material and structure of the scaffold for a variety of in-vitro applications, is anticipated to boost revenue generation for scaffolds. Recent research has explored the use of a broad range of scaffolds, such as graphene scaffolds, nanofibers, natural marine collagen, freeze-casting, and others. In addition, emerging applications of techniques such as lab-on-a-chip in several assay types, including proliferation, stimulation, viability, transport, high content screening, patch clamping, and metabolic activity are anticipated to lead to an increase in demand for advanced and efficient solutions.

However, the lack of consistency in 3D cell model products is one of the major drawbacks that is expected to hinder the growth of the market. Moreover, various factors such as variability in cell culture, standardized challenges, scale & manufacturing issues, and quality control issues might hamper the market growth.

3D Cell Culture Market Report Highlights:

  • The scaffold-based technology segment dominated the market in 2023 with a revenue share of 48.94% and is attributed to the increasing application of scaffold-based cultures in tissue engineering and regenerative medicine applications
  • Stem cell research & tissue engineering held the largest share in 2023, whereas the cancer institute segment is expected to witness the fastest growth owing to the rising prevalence of cancer, and the benefits offered by 3D cell cultures in cancer research
  • In the end-use segment, biotechnology and pharmaceutical companies dominated the market with a revenue share in 2023. The higher revenue growth is attributed to the continuous growth and commercial success of biopharmaceuticals coupled with the expanding portfolio of the major pharmaceutical companies
  • North America region dominated the global market in 2023 with a revenue share of 38.97%, owing to the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Technology Segment
    • 1.1.2. Application Segment
    • 1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis:
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for organ transplantation & tissue engineering
      • 3.2.1.2. Technological advancements in scaffold free technology
      • 3.2.1.3. Rise in investments and R&D funding for cell-based research
      • 3.2.1.4. Increasing focus on developing alternative to animal testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with implementation
      • 3.2.2.2. Lack of compatibility and consistency
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. 3D Cell Culture Market: Technology Movement Analysis
  • 4.2. Scaffold Based
    • 4.2.1. Scaffold based market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Hydrogels
      • 4.2.2.1. Hydrogels market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Polymeric Scaffolds
      • 4.2.3.1. Polymeric scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Micropatterned Surface Microplates
      • 4.2.4.1. Micropatterned surface microplates market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Nanofiber Based Scaffolds
      • 4.2.5.1. Nanofiber based scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3. Scaffold Free
    • 4.3.1. Scaffold free market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Hanging Drop Microplates
      • 4.3.2.1. Hanging drop microplates market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Spheroid Microplates with ULA coating
      • 4.3.3.1. Spheroid microplates with ULA coating market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Magnetic Levitation
      • 4.3.4.1. Magnetic levitation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4. Bioreactors
    • 4.4.1. Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Microfluidics
    • 4.5.1. Microfluidics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Bioprinting
    • 4.6.1. Bioprinting market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. 3D Cell Culture Market: Application Movement Analysis
  • 5.2. Cancer Research
    • 5.2.1. Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3. Stem Cell Research & Tissue Engineering
    • 5.3.1. Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Drug Development & Toxicity Testing
    • 5.4.1. Drug development & toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. End-Use Business Analysis

  • 6.1. 3D Cell Culture Market: End-Use Movement Analysis
  • 6.2. Biotechnology & Pharmaceutical Companies
    • 6.2.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. 3D Cell Culture Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Target Disease Prevalence
      • 7.2.2.4. U.S. 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Target Disease Prevalence
      • 7.2.3.4. Canada 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Target Disease Prevalence
      • 7.3.2.4. UK 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Target Disease Prevalence
      • 7.3.3.4. Germany 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Target Disease Prevalence
      • 7.3.4.4. France 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Target Disease Prevalence
      • 7.3.5.4. Italy 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Target Disease Prevalence
      • 7.3.6.4. Spain 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Target Disease Prevalence
      • 7.3.7.4. Denmark 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Target Disease Prevalence
      • 7.3.8.4. Sweden 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Target Disease Prevalence
      • 7.3.9.4. Norway 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Target Disease Prevalence
      • 7.4.2.4. Japan 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Target Disease Prevalence
      • 7.4.3.4. China 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Target Disease Prevalence
      • 7.4.4.4. India 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Target Disease Prevalence
      • 7.4.5.4. Australia 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Target Disease Prevalence
      • 7.4.6.4. Thailand 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Target Disease Prevalence
      • 7.4.7.4. South Korea 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Target Disease Prevalence
      • 7.5.2.4. Brazil 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Target Disease Prevalence
      • 7.5.3.4. Mexico 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Target Disease Prevalence
      • 7.5.4.4. Argentina 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Target Disease Prevalence
      • 7.6.2.4. South Africa 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Target Disease Prevalence
      • 7.6.3.4. Saudi Arabia 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Target Disease Prevalence
      • 7.6.4.4. UAE 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Target Disease Prevalence
      • 7.6.5.4. Kuwait 3D Cell Culture, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. PromoCell GmbH
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Corning Incorporated
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Avantor, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Tecan Trading AG
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. REPROCELL Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Product Benchmarking
      • 8.4.8.3. Strategic Initiatives
    • 8.4.9. CN Bio Innovations Ltd.
      • 8.4.9.1. Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. Lena Biosciences
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives